Collectively, this work suggests a two-step activation process where initial stimulation of the CRCs with butyrate or propionate changes their ability to activate CD8+ T cells while also priming the CRC cells to respond to signals emitted by the activated T cells. Here, CD8A is linked to colorectal carcinoma.